David E Vaillancourt Selected Research

David E Vaillancourt Research Topics

Disease

22	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2004
8	Dystonia (Limb Dystonia) 01/2021 - 06/2014
7	Parkinsonian Disorders (Parkinsonism) 01/2020 - 11/2013
6	Dystonia musculorum deformans type 1 01/2021 - 10/2017
5	Disease Progression 01/2022 - 08/2016
4	Tremor (Tremors) 01/2013 - 09/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 11/2016
3	Hypokinesia (Bradykinesia) 04/2016 - 03/2004
2	Movement Disorders (Movement Disorder) 06/2014 - 08/2011
1	Brain Concussion (Cerebral Concussion) 01/2022
1	Cognitive Dysfunction 01/2022
1	Neurodevelopmental Disorders 01/2022
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Atrophy 01/2022
1	Prodromal Symptoms 10/2021
1	Synucleinopathies 01/2020
1	Dementia (Dementias) 01/2020
1	Multiple System Atrophy 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Amyloidosis 11/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Torticollis (Wryneck) 12/2018
1	Dyskinesias (Dyskinesia) 04/2016
1	Neurobehavioral Manifestations 01/2016
1	Pain (Aches) 01/2015
1	Essential Tremor (Essential Tremors) 08/2011

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2017
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2010
4	Levodopa (L Dopa)FDA LinkGeneric 01/2018 - 12/2013
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2021
2	rasagiline (Azilect)FDA Link 01/2022 - 01/2016
2	neuromelaninIBA 10/2021 - 10/2018
2	IronIBA 10/2021 - 10/2018
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2021
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2021 - 01/2020
2	SynucleinsIBA 01/2020 - 01/2018
1	Chitinase-3-Like Protein 1IBA 01/2022
1	visininIBA 01/2022
1	Nicotine FDA Link 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Synaptosomal-Associated Protein 25IBA 01/2022
1	NeurograninIBA 01/2022
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021
1	florbetapirIBA 01/2021
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2021
1	MuscarineIBA 01/2021
1	Neomycin FDA LinkGeneric 01/2021
1	HIV Protease InhibitorsIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	QuinpiroleIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	PotassiumIBA 12/2020
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 12/2020
1	CalciumIBA 12/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	TropomyosinIBA 01/2020
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	EnzymesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Prednisolone (Predate)FDA LinkGeneric 11/2018
1	Muscarinic AntagonistsIBA 10/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2017
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2017
1	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2017
1	aducanumabIBA 11/2016
1	Monoamine Oxidase (MAO)IBA 01/2016
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016
1	phenylsaligenin cyclic phosphate (PSCP)IBA 01/2015
1	Dopamine (Intropin)FDA LinkGeneric 12/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 12/2013

Therapy/Procedure

8	Deep Brain Stimulation 12/2018 - 03/2004
7	Therapeutics 01/2022 - 03/2004
3	Transcranial Magnetic Stimulation 12/2018 - 06/2014
2	Electrodes (Electrode) 01/2006 - 03/2004
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2019
1	Activities of Daily Living (ADL) 08/2011